Drug Type Small molecule drug |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Molecular FormulaC6H15ClN2O2 |
InChIKeyAIXAANGOTKPUOY-UHFFFAOYSA-N |
CAS Registry51-83-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Presbyopia | IND Approval | CN | 08 Jan 2024 | |
Presbyopia | IND Approval | CN | Visus Therapeutics, Inc.Startup | 08 Jan 2024 |